StockData
enVVeno Medical Corp logo

enVVeno Medical Corp (NVNO) stock

NVNONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 6/30
$5.77+0.00 (0.00%)

Close on Nov 18, 2026Market cap $4.01MP/E –Yield –

enVVeno Medical r&d expenses

Research and development expenses are spending on new products and technology.

enVVeno Medical's R&D Expenses for the twelve months ending Sep 30, 2026 was $9.01M, down 22.0% year over year. For fiscal 2025 it was $9.98M, down 18.5% from the year before. The highest annual figure on record is $13.58M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$9.98M-18.5%
FY2024Dec 31, 2024$12.25M-9.8%
FY2023Dec 31, 2023$13.58M+37.0%
FY2022Dec 31, 2022$9.91M+73.1%
FY2021Dec 31, 2021$5.73M+34.7%
FY2020Dec 31, 2020$4.25M+92.7%
FY2019Dec 31, 2019$2.21M+78.1%
FY2018Dec 31, 2018$1.24M+90.7%
FY2017Dec 31, 2017$649.74K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$2.88M+11.3%
Q2 FY2026Jun 30, 2026$2.08M-28.2%
Q1 FY2026Mar 31, 2026$2.11M-17.4%
Q4 FY2025Dec 31, 2025$1.95M-44.5%
Q3 FY2025Sep 30, 2025$2.59M-9.6%
Q2 FY2025Jun 30, 2025$2.89M+2.3%
Q1 FY2025Mar 31, 2025$2.56M-16.2%
Q4 FY2024Dec 31, 2024$3.51M+17.8%
Q3 FY2024Sep 30, 2024$2.86M+2.2%
Q2 FY2024Jun 30, 2024$2.83M-33.0%
Q1 FY2024Mar 31, 2024$3.05M-15.1%
Q4 FY2023Dec 31, 2023$2.98M+6.6%
Q3 FY2023Sep 30, 2023$2.80M+12.3%
Q2 FY2023Jun 30, 2023$4.21M+37.1%
Q1 FY2023Mar 31, 2023$3.60M+131.6%
Q4 FY2022Dec 31, 2022$2.80M+57.0%
Q3 FY2022Sep 30, 2022$2.49M+103.4%
Q2 FY2022Jun 30, 2022$3.07M+181.9%
Q1 FY2022Mar 31, 2022$1.55M-4.9%
Q4 FY2021Dec 31, 2021$1.78M-21.7%
Q3 FY2021Sep 30, 2021$1.23M+61.6%
Q2 FY2021Jun 30, 2021$1.09M+54.4%
Q1 FY2021Mar 31, 2021$1.63M+219.6%
Q4 FY2020Dec 31, 2020$2.28M+189.1%
Q3 FY2020Sep 30, 2020$758.20K+12.0%
Q2 FY2020Jun 30, 2020$706.17K+64.9%
Q1 FY2020Mar 31, 2020$510.62K+63.1%
Q4 FY2019Dec 31, 2019$787.83K+168.7%
Q3 FY2019Sep 30, 2019$676.97K+59.4%
Q2 FY2019Jun 30, 2019$428.31K+52.7%
Q1 FY2019Mar 31, 2019$313.01K+30.2%
Q4 FY2018Dec 31, 2018$293.24K-16.0%
Q3 FY2018Sep 30, 2018$424.60K+885.9%
Q2 FY2018Jun 30, 2018$280.42K+51.6%
Q1 FY2018Mar 31, 2018$240.49K–
Q4 FY2017Dec 31, 2017$349.09K–
Q3 FY2017Sep 30, 2017$43.07K–
Q2 FY2017Jun 30, 2017$184.92K–

More enVVeno Medical figures

See a number that looks wrong?